The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas,…
| Price | $55.48 |
|---|---|
| Market cap | $10.82B |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NASDAQ |
| 52-week range | 51.01-89.83 |
| Beta | 0.82 |
Explore COO's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.